Delivery Order SPE2DX22D0010-SPE2D825FFR57
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$5.1K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,127.60, was issued by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA) Troop Support. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Focalin XR capsules, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a completion date of September 24, 2024 and is structured as a firm-fixed price delivery order. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,046.54 firm fixed-price delivery order is for the supply of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,186.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,678.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $6,861.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR capsules, a brand-name medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $4,960.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR Capsules, 10mg, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 1, 2025. This award is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.50 firm-fixed-price delivery order is for the supply of Focalin XR Capsules, 20mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $4,899.69, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Focalin XR Capsules 10mg, a pharmaceutical product used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract is a delivery order with a firm fixed price and has an ultimate completion date of January 29, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award, valued at $3,629.46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for Focalin XR capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.18 firm fixed-price delivery order is for the supply of Focalin XR 10 mg capsules, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2022. AmerisourceBergen holds a...